Monday, April 20, 2026

Nemea Therapeutics is a preclinical-stage company developing oral small molecule inhibitors targeting mitochondrial RNA polymerase (POLRMT) for the treatment of mitochondria-dependent solid tumors.

Ecoatex transforms agricultural and marine byproducts—such as nutshells, crop residues, and seaweed—into advanced cellulose-based materials using a patent-pending green-chemistry process.

The platform produces engineered cellulose materials, coating formulations, and specialty cellulose intermediates for packaging, coated materials, nonwovens, and other industrial applications.

By converting waste biomass into fully biodegradable, renewable materials that eliminate toxic chemicals and reduce water, energy, and carbon footprints, Ecoatex enables scalable, circular manufacturing using existing manufacturing equipment, helping manufacturers lower material costs, reduce reliance on fossil-based inputs, and adopt lower-impact alternatives without major process changes.

Annoviant is advancing patient outcomes in heart disease by delivering innovative, regenerative cardiovascular devices built on its proprietary TxGuard™ soft-tissue technology.

The platform enables durable, off-the-shelf solutions that address critical unmet needs in heart valve disease and coronary artery bypass grafting—helping patients live healthier lives while reducing long-term healthcare costs.

Fibarcode is a fiber-based, embedded textile labeling technology that enables durable authentication, traceability, and end-of-use data management across the entire product life cycle—while minimizing disruption to recycling processes.

Avast Therapeutics is developing first-in-class, non-invasive peptide therapeutics that safely cross the blood-brain barrier to restore mitochondrial function and protect neurons.

This breakthrough approach targets neurodegenerative diseases such as Parkinson’s and Alzheimer’s at their earliest stages, with the potential to halt disease progression and transform brain medicine.

Clarus Labs builds a portable kinetic-fluorogenic platform that delivers on-site, lab-grade oxidation (rancidity) testing for meat and pet food in under 10 minutes.

This enables manufacturers to verify freshness, optimize antioxidant dosing, and reduce waste—while creating a scalable platform for future tests in food, environmental, and diagnostic applications.

Bluegrass Pharmaceuticals develops advanced Lipid Nanoparticles (LNPs) to enhance vaccine efficacy and enable targeted therapeutic delivery.

Coulomb Technology is pioneering next-generation sodium-ion batteries that are fire-safe, durable, and environmentally sustainable.

By moving beyond lithium, we reduce dependence on critical foreign minerals and promote domestic manufacturing to strengthen U.S. energy security.

Our innovative battery technology delivers reliable, cost-effective, and eco-friendly power solutions for renewable energy integration, electric mobility, and defense—supporting a cleaner, safer, and more self-reliant energy future.

Kifa Therapeutics advances highly selective CNS-kinase inhibitors, starting with a G2019S-LRRK2 therapy for Parkinson’s disease.

Our strategy pairs genetics-based patient selection with validated biomarkers to enable efficient clinical studies and an orphan, accelerated-approval path.

Soteria Formulations develops biodegradable, microplastic-free delivery platforms that extend shelf life and field performance of lower inputs of diverse agrobiologicals and agrochemicals.

SelSym Biotech is pioneering hemostasis with SymClot, an innovative platelet-mimetic therapy that promises to dramatically improve patient survival and outcomes by rapidly stopping bleeding after severe trauma and high-risk surgeries.

VibraPower powers the next generation of intelligent factories by harvesting machine vibrations to fuel AI-enabled sensors—creating self-sustaining, battery-free networks that drive autonomous maintenance and real-time industrial intelligence.

Moonlight Therapeutics is a clinical-stage biotech company developing MOON101, a novel microneedle stamp treatment for peanut allergy that delivers allergen proteins directly into the skin to safely desensitize the immune system.

Nhu Energy provides innovative digital operating technology that transforms distributed energy resources into resilient energy storage microgrids.

These microgrids deliver year-round ROI, clean energy, and reliable uninterrupted power for mission-critical commercial-industrial, utility, and defense facilities.

Solutions are de-risked upfront with state-of-the-art hardware-in-the-loop simulation testing and supported over the asset’s life through trademarked Operating Technology as a Service (OTaaS®).

At Myosin Therapeutics, we’re tackling aggressive, treatment-resistant cancers by targeting a completely new frontier in cancer biology—the molecular nanomotors that power cancer cell movement, invasion, and survival.

PolyPV develops lightweight, flexible organic solar modules that provide reliable power in remote and off-grid environments where traditional rigid panels are impractical.

PHIOGEN is a pre-clinical-stage biotechnology company developing first-in-class immunizing therapeutics designed to both treat drug-resistant infections and induce durable immune protection against recurrence, with a focus on chronic conditions. 
 

Fathom Science harnesses AI and weather-ocean modeling to power smarter maritime decisions—boosting safety, sustainability, and success across the blue economy.

TNT Eco Materials has developed Fiber Grow™, a patented calcium-carbonate mineralization process that transforms renewable hemp, seaweed, and polymer fibers into high-performance, sustainable materials.

Fiber Grow™ strengthens and enhances the thermal efficiency of concrete while providing lightweight, fire-resistant alternatives for drywall, insulation, and composite panels.

Neurodiverse Technologies develops adaptive, research-driven simulation platforms that empower neurodivergent individuals to build real-world readiness and confidence.

Our products—including SANDI for driver readiness and NAVIS for interview and employment preparation—combine neuroscience, virtual reality, and machine learning to create accessible, data-informed training environments.

As a Vanderbilt University spin-off, we bridge academic innovation and real-world impact, helping individuals gain independence while enabling institutions to deliver evidence-based readiness programs at scale.

Aspira Medical is developing a wearable ultrasound platform that enables continuous noninvasive monitoring of gastric distension to provide early detection and prevention of aspiration pneumonia in critically ill ICU patients.

Atomistic Insights uses physics-based AI to reveal how proteins move and uncover hidden binding sites, enabling faster discovery of more effective medicines.

EndoLimb is developing the EndoThumb—an implantable, skin-covered prosthetic thumb that restores natural appearance, touch sensation, and critical hand function for thumb amputation patients.

Mobius AI, Inc. orchestrates certainty in an uncertain world.

We are building the operating system for digital orchestration of the physical world—starting with mobility and non-emergency medical transportation (NEMT).

InTailor Bariatrics has developed a non-surgical, non-pharmacological weight-loss technology that reduces stomach volume using an easy-to-operate endoscopic device.

The automated endoscopic gastroplasty delivers consistent, reproducible results in a 15-minute procedure, enabling durable weight loss through caloric restriction without anatomic disruption.

Plaid Semiconductors is building a next-generation hardware platform that fits the computing power of an entire data center rack onto a single substrate.

This breakthrough delivers unprecedented performance in compute density, bandwidth, and energy efficiency—far beyond today’s semiconductor technologies.

Ground Control Robotics has developed SCUTTLE—a centipede-like robot designed to reliably navigate complex, cluttered, and confined environments, solving the dull, dirty, and dangerous challenges in pest control.